Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Gentium SpA
Jazz Pharmaceuticals
Information provided by (Responsible Party):
Gentium SpA Identifier:
First received: February 25, 2008
Last updated: November 14, 2014
Last verified: November 2014